Book Navigation

Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks.

Overview
Title:
Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks.
Authors:
Flanders S, Brown B, Massoudi M, Schultz N, Ramaswamy K
Journal:
J Manag Care Spec Pharm
Publication date:
2017
Volume:
23
Issue:
11
First page:
1202
ISSN:
2376-1032
Link to pubmed:
http://www.ncbi.nlm.nih.gov/pubmed/29083976
Publication type:
Journal
Preview

Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks. Flanders S, Brown B, Massoudi M, Schultz N, Ramaswamy K. J Manag Care Spec Pharm 2017; 23(11):1202.

Page last updated: Jul 02, 2018
Back to top